Skip to main content
S&P 5007,551.81-0.45%DOW51,461.90-1.21%NASDAQ25,978.42-0.01%BTC$76,193.00+0.69%ETH$2,416.18+0.62%GOLD$4,309.80-1.77%OIL$101.77-0.64%
Smart Investors Daily
SO

OTC · SOAGY

Sartorius AG

Healthcare · Medical - Instruments & Supplies

$56.12

Up+$1.16 (+2.12%)

Updated Sep 16, 2026, 10:09 PM

SID Score

5.3/10

Composite research score

Smart Money

46/100

Neutral

Market cap
84.89B
P/E ratio
100.05
Dividend yield
0.27%
52-week range
— – —
Volume
200
Avg. volume
6.59K

Price performance

SOAGY price history

1M range · 0 trading sessions · Daily adjusted prices

SOAGY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SOAGY news

The latest Smart Investors Daily articles mentioning SOAGY.

Stock researchCompany · Overview

SOAGY research

Overview

Company profile and research snapshot.

Company profile

SARTORIUS ADR 1/5 PREF SH

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
—
Implied upside
—
Analysts
2
SOAGY recent ratings
DateFirmRatingTarget
Jul 13, 2026ROTHSCHILD & CO REDBURNBuy—
Apr 22, 2026JEFFERIESBuy—
Jan 8, 2026ROTHSCHILD & CO REDBURNBuy—
Jan 7, 2026ROTHSCHILD & CO REDBURNBuy—
Oct 22, 2025ROTHSCHILD & CO REDBURNBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 9, 2026

Assessing Sartorius (XTRA:SRT3) Valuation After Recent Share Weakness And Long Term Decline

Recent share performance and business snapshot Sartorius (XTRA:SRT3) is back on many investors’ screens after recent price moves, with the share down about 7% over the past month but slightly positive over the past 3 months. The company reports revenue of €3.52b and net income of €133.6m, reflecting annual growth rates provided for both lines. That context helps you weigh recent share performance against the current earnings base. See our latest analysis for Sartorius. At a share price of...

Yahoo · Feb 3, 2026

Sartorius Aktiengesellschaft Q4 Earnings Call Highlights

Sartorius Aktiengesellschaft (ETR:SRT) reported preliminary full-year 2025 results showing a return to “normal” demand behavior for consumables, while customer investment in equipment and instruments remained cautious. Management said improved demand trends—particularly in recurring revenue—combined

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By